First Time Loading...

Merck KGaA
XETRA:MRK

Watchlist Manager
Merck KGaA Logo
Merck KGaA
XETRA:MRK
Watchlist
Price: 165.85 EUR 4.77% Market Closed
Updated: May 16, 2024

Merck KGaA
Research & Development

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Merck KGaA
Research & Development Peer Comparison

Comparables:
ATAI
BAYN
93M1
DMP
PSG

Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
Merck KGaA
XETRA:MRK
Research & Development
-€2.4B
CAGR 3-Years
-3%
CAGR 5-Years
-2%
CAGR 10-Years
-5%
ATAI Life Sciences NV
NASDAQ:ATAI
Research & Development
-$62.2m
CAGR 3-Years
-76%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bayer AG
XETRA:BAYN
Research & Development
-€5.4B
CAGR 3-Years
9%
CAGR 5-Years
-1%
CAGR 10-Years
-5%
MPH Health Care AG
XETRA:93M1
Research & Development
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Dermapharm Holding SE
XETRA:DMP
Research & Development
-€10.6m
CAGR 3-Years
6%
CAGR 5-Years
-9%
CAGR 10-Years
N/A
PharmaSGP Holding SE
XETRA:PSG
Research & Development
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Merck KGaA's Research & Development?
Research & Development
-2.4B EUR

Based on the financial report for Dec 31, 2023, Merck KGaA's Research & Development amounts to -2.4B EUR.

What is Merck KGaA's Research & Development growth rate?
Research & Development CAGR 10Y
-5%

Over the last year, the Research & Development growth was 0%. The average annual Research & Development growth rates for Merck KGaA have been -3% over the past three years , -2% over the past five years , and -5% over the past ten years .